Table of Content

1 Study Coverage
1.1 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Vials
1.2.3 Prefilled
1.3 Market by Application
1.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Myelosuppressive Chemotherapy
1.3.3 Leukemia Chemotherapy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Estimates and Forecasts 2018-2029
2.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region
2.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region (2018-2024)
2.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region (2024-2029)
2.2.4 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Region (2018-2029)
2.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Estimates and Forecasts 2018-2029
2.4 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region
2.4.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region (2018-2024)
2.4.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region (2024-2029)
2.4.4 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Manufacturers
3.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Manufacturers (2018-2024)
3.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) in 2022
3.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Manufacturers
3.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Manufacturers (2018-2024)
3.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue in 2022
3.3 Global Key Players of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF), Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF), Product Offered and Application
3.8 Global Key Manufacturers of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type
4.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Historical Sales by Type (2018-2024)
4.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Forecasted Sales by Type (2024-2029)
4.1.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Type (2018-2029)
4.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type
4.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Historical Revenue by Type (2018-2024)
4.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Forecasted Revenue by Type (2024-2029)
4.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Type (2018-2029)
4.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price by Type
4.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price by Type (2018-2024)
4.3.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application
5.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Historical Sales by Application (2018-2024)
5.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Forecasted Sales by Application (2024-2029)
5.1.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Application (2018-2029)
5.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application
5.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Historical Revenue by Application (2018-2024)
5.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Forecasted Revenue by Application (2024-2029)
5.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Application (2018-2029)
5.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price by Application
5.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price by Application (2018-2024)
5.3.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Type
6.1.1 US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2018-2029)
6.1.2 US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2018-2029)
6.2 US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Application
6.2.1 US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2018-2029)
6.2.2 US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2018-2029)
6.3 US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Country
6.3.1 US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2018-2029)
6.3.3 US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Type
7.1.1 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2018-2029)
7.1.2 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2018-2029)
7.2 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Application
7.2.1 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2018-2029)
7.2.2 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2018-2029)
7.3 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Country
7.3.1 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2018-2029)
7.3.3 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size
8.1.1 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (2018-2029)
8.1.2 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue (2018-2029)
8.2 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Application
8.2.1 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2018-2029)
8.2.2 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Type
9.1.1 Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2018-2029)
9.1.2 Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2018-2029)
9.2 Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Application
9.2.1 Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2018-2029)
9.2.2 Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2018-2029)
9.3 Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region
9.3.1 Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region (2018-2029)
9.3.3 Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Type
10.1.1 Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Application
10.2.1 Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country
10.3.1 Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Overview
11.1.3 Abbott Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Abbott Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Recent Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Overview
11.2.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Amgen Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen Recent Developments
11.3 Arven Pharmaceuticals
11.3.1 Arven Pharmaceuticals Company Information
11.3.2 Arven Pharmaceuticals Overview
11.3.3 Arven Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Arven Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Arven Pharmaceuticals Recent Developments
11.4 Biocon
11.4.1 Biocon Company Information
11.4.2 Biocon Overview
11.4.3 Biocon Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Biocon Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biocon Recent Developments
11.5 Cadila Pharmaceuticals
11.5.1 Cadila Pharmaceuticals Company Information
11.5.2 Cadila Pharmaceuticals Overview
11.5.3 Cadila Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Cadila Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Cadila Pharmaceuticals Recent Developments
11.6 Dr.Reddy's Laboratories
11.6.1 Dr.Reddy's Laboratories Company Information
11.6.2 Dr.Reddy's Laboratories Overview
11.6.3 Dr.Reddy's Laboratories Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Dr.Reddy's Laboratories Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Dr.Reddy's Laboratories Recent Developments
11.7 Emcure Pharmaceuticals
11.7.1 Emcure Pharmaceuticals Company Information
11.7.2 Emcure Pharmaceuticals Overview
11.7.3 Emcure Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Emcure Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Emcure Pharmaceuticals Recent Developments
11.8 Intas Pharmaceuticals
11.8.1 Intas Pharmaceuticals Company Information
11.8.2 Intas Pharmaceuticals Overview
11.8.3 Intas Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Intas Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Intas Pharmaceuticals Recent Developments
11.9 Kyowa Kirin
11.9.1 Kyowa Kirin Company Information
11.9.2 Kyowa Kirin Overview
11.9.3 Kyowa Kirin Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Kyowa Kirin Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Kyowa Kirin Recent Developments
11.10 Novartis
11.10.1 Novartis Company Information
11.10.2 Novartis Overview
11.10.3 Novartis Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Novartis Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis Recent Developments
11.11 Pfizer
11.11.1 Pfizer Company Information
11.11.2 Pfizer Overview
11.11.3 Pfizer Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Pfizer Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Pfizer Recent Developments
11.12 Reliance Life Sciences
11.12.1 Reliance Life Sciences Company Information
11.12.2 Reliance Life Sciences Overview
11.12.3 Reliance Life Sciences Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Reliance Life Sciences Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Reliance Life Sciences Recent Developments
11.13 Harbin Pharmaceutical
11.13.1 Harbin Pharmaceutical Company Information
11.13.2 Harbin Pharmaceutical Overview
11.13.3 Harbin Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Harbin Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Harbin Pharmaceutical Recent Developments
11.14 North China Pharmaceutical
11.14.1 North China Pharmaceutical Company Information
11.14.2 North China Pharmaceutical Overview
11.14.3 North China Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 North China Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 North China Pharmaceutical Recent Developments
11.15 Jiuyuan Gene
11.15.1 Jiuyuan Gene Company Information
11.15.2 Jiuyuan Gene Overview
11.15.3 Jiuyuan Gene Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Jiuyuan Gene Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Jiuyuan Gene Recent Developments
11.16 Kexing Biopharm
11.16.1 Kexing Biopharm Company Information
11.16.2 Kexing Biopharm Overview
11.16.3 Kexing Biopharm Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Kexing Biopharm Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Kexing Biopharm Recent Developments
11.17 Qilu Pharmaceutical
11.17.1 Qilu Pharmaceutical Company Information
11.17.2 Qilu Pharmaceutical Overview
11.17.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Qilu Pharmaceutical Recent Developments
11.18 Quangang Pharmaceutical
11.18.1 Quangang Pharmaceutical Company Information
11.18.2 Quangang Pharmaceutical Overview
11.18.3 Quangang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Quangang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Quangang Pharmaceutical Recent Developments
11.19 Sunway Biotech
11.19.1 Sunway Biotech Company Information
11.19.2 Sunway Biotech Overview
11.19.3 Sunway Biotech Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Sunway Biotech Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Sunway Biotech Recent Developments
11.20 SL Pharmaceutical
11.20.1 SL Pharmaceutical Company Information
11.20.2 SL Pharmaceutical Overview
11.20.3 SL Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.20.4 SL Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 SL Pharmaceutical Recent Developments
11.21 Four Rings Bio-Pharmaceutical
11.21.1 Four Rings Bio-Pharmaceutical Company Information
11.21.2 Four Rings Bio-Pharmaceutical Overview
11.21.3 Four Rings Bio-Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.21.4 Four Rings Bio-Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Four Rings Bio-Pharmaceutical Recent Developments
11.22 Amoytop
11.22.1 Amoytop Company Information
11.22.2 Amoytop Overview
11.22.3 Amoytop Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.22.4 Amoytop Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Amoytop Recent Developments
11.23 Wuzhong Pharmaceutical
11.23.1 Wuzhong Pharmaceutical Company Information
11.23.2 Wuzhong Pharmaceutical Overview
11.23.3 Wuzhong Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Price, Revenue and Gross Margin (2018-2024)
11.23.4 Wuzhong Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Wuzhong Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Industry Chain Analysis
12.2 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Production Mode & Process
12.4 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales and Marketing
12.4.1 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Channels
12.4.2 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Distributors
12.5 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Customers
13 Market Dynamics
13.1 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Industry Trends
13.2 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Drivers
13.3 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Challenges
13.4 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Restraints
14 Key Findings in The Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Vials
Table 3. Major Manufacturers of Prefilled
Table 4. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Region (2018-2024)
Table 9. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Region (2024-2029)
Table 10. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region (2018-2024) & (K L)
Table 12. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region (2024-2029) & (K L)
Table 13. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Region (2018-2024)
Table 14. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Region (2024-2029)
Table 15. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Manufacturers (2018-2024) & (K L)
Table 16. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Share by Manufacturers (2018-2024)
Table 17. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF), Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price by Manufacturers 2018-2024 (US$/L)
Table 21. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) as of 2022)
Table 23. Global Key Manufacturers of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF), Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF), Product Offered and Application
Table 25. Global Key Manufacturers of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF), Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2018-2024) & (K L)
Table 28. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2024-2029) & (K L)
Table 29. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Share by Type (2018-2024)
Table 30. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Share by Type (2024-2029)
Table 31. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Share by Type (2018-2024)
Table 34. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Share by Type (2024-2029)
Table 35. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price by Type (2018-2024) & (US$/L)
Table 36. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price Forecast by Type (2024-2029) & (US$/L)
Table 37. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2018-2024) & (K L)
Table 38. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2024-2029) & (K L)
Table 39. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Share by Application (2018-2024)
Table 40. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Share by Application (2024-2029)
Table 41. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Share by Application (2018-2024)
Table 44. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Share by Application (2024-2029)
Table 45. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price by Application (2018-2024) & (US$/L)
Table 46. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price Forecast by Application (2024-2029) & (US$/L)
Table 47. US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2018-2024) & (K L)
Table 48. US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2024-2029) & (K L)
Table 49. US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2018-2024) & (K L)
Table 52. US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2024-2029) & (K L)
Table 53. US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2018-2024) & (K L)
Table 59. US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2024-2029) & (K L)
Table 60. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2018-2024) & (K L)
Table 61. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2024-2029) & (K L)
Table 62. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2018-2024) & (K L)
Table 65. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2024-2029) & (K L)
Table 66. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2018-2024) & (K L)
Table 72. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2024-2029) & (K L)
Table 73. China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2018-2024) & (K L)
Table 74. China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2024-2029) & (K L)
Table 75. China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2018-2024) & (K L)
Table 78. China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2024-2029) & (K L)
Table 79. China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2018-2024) & (K L)
Table 82. Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2024-2029) & (K L)
Table 83. Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2018-2024) & (K L)
Table 86. Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2024-2029) & (K L)
Table 87. Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region (2018-2024) & (K L)
Table 93. Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region (2024-2029) & (K L)
Table 94. Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2018-2024) & (K L)
Table 95. Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2024-2029) & (K L)
Table 96. Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2018-2024) & (K L)
Table 99. Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2024-2029) & (K L)
Table 100. Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2018-2024) & (K L)
Table 106. Middle East, Africa and Latin America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2024-2029) & (K L)
Table 107. Abbott Company Information
Table 108. Abbott Description and Major Businesses
Table 109. Abbott Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 110. Abbott Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Abbott Recent Developments
Table 112. Amgen Company Information
Table 113. Amgen Description and Major Businesses
Table 114. Amgen Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 115. Amgen Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Amgen Recent Developments
Table 117. Arven Pharmaceuticals Company Information
Table 118. Arven Pharmaceuticals Description and Major Businesses
Table 119. Arven Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 120. Arven Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Arven Pharmaceuticals Recent Developments
Table 122. Biocon Company Information
Table 123. Biocon Description and Major Businesses
Table 124. Biocon Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 125. Biocon Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Biocon Recent Developments
Table 127. Cadila Pharmaceuticals Company Information
Table 128. Cadila Pharmaceuticals Description and Major Businesses
Table 129. Cadila Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 130. Cadila Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Cadila Pharmaceuticals Recent Developments
Table 132. Dr.Reddy's Laboratories Company Information
Table 133. Dr.Reddy's Laboratories Description and Major Businesses
Table 134. Dr.Reddy's Laboratories Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 135. Dr.Reddy's Laboratories Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Dr.Reddy's Laboratories Recent Developments
Table 137. Emcure Pharmaceuticals Company Information
Table 138. Emcure Pharmaceuticals Description and Major Businesses
Table 139. Emcure Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 140. Emcure Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Emcure Pharmaceuticals Recent Developments
Table 142. Intas Pharmaceuticals Company Information
Table 143. Intas Pharmaceuticals Description and Major Businesses
Table 144. Intas Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 145. Intas Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Intas Pharmaceuticals Recent Developments
Table 147. Kyowa Kirin Company Information
Table 148. Kyowa Kirin Description and Major Businesses
Table 149. Kyowa Kirin Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 150. Kyowa Kirin Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Kyowa Kirin Recent Developments
Table 152. Novartis Company Information
Table 153. Novartis Description and Major Businesses
Table 154. Novartis Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 155. Novartis Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Novartis Recent Developments
Table 157. Pfizer Company Information
Table 158. Pfizer Description and Major Businesses
Table 159. Pfizer Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 160. Pfizer Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Pfizer Recent Developments
Table 162. Reliance Life Sciences Company Information
Table 163. Reliance Life Sciences Description and Major Businesses
Table 164. Reliance Life Sciences Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 165. Reliance Life Sciences Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Reliance Life Sciences Recent Developments
Table 167. Harbin Pharmaceutical Company Information
Table 168. Harbin Pharmaceutical Description and Major Businesses
Table 169. Harbin Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 170. Harbin Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Harbin Pharmaceutical Recent Developments
Table 172. North China Pharmaceutical Company Information
Table 173. North China Pharmaceutical Description and Major Businesses
Table 174. North China Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 175. North China Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. North China Pharmaceutical Recent Developments
Table 177. Jiuyuan Gene Company Information
Table 178. Jiuyuan Gene Description and Major Businesses
Table 179. Jiuyuan Gene Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 180. Jiuyuan Gene Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Jiuyuan Gene Recent Developments
Table 182. Kexing Biopharm Company Information
Table 183. Kexing Biopharm Description and Major Businesses
Table 184. Kexing Biopharm Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 185. Kexing Biopharm Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Kexing Biopharm Recent Developments
Table 187. Qilu Pharmaceutical Company Information
Table 188. Qilu Pharmaceutical Description and Major Businesses
Table 189. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 190. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Qilu Pharmaceutical Recent Developments
Table 192. Quangang Pharmaceutical Company Information
Table 193. Quangang Pharmaceutical Description and Major Businesses
Table 194. Quangang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 195. Quangang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Quangang Pharmaceutical Recent Developments
Table 197. Sunway Biotech Company Information
Table 198. Sunway Biotech Description and Major Businesses
Table 199. Sunway Biotech Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 200. Sunway Biotech Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. Sunway Biotech Recent Developments
Table 202. SL Pharmaceutical Company Information
Table 203. SL Pharmaceutical Description and Major Businesses
Table 204. SL Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 205. SL Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 206. SL Pharmaceutical Recent Developments
Table 207. Four Rings Bio-Pharmaceutical Company Information
Table 208. Four Rings Bio-Pharmaceutical Description and Major Businesses
Table 209. Four Rings Bio-Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 210. Four Rings Bio-Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 211. Four Rings Bio-Pharmaceutical Recent Developments
Table 212. Amoytop Company Information
Table 213. Amoytop Description and Major Businesses
Table 214. Amoytop Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 215. Amoytop Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 216. Amoytop Recent Developments
Table 217. Wuzhong Pharmaceutical Company Information
Table 218. Wuzhong Pharmaceutical Description and Major Businesses
Table 219. Wuzhong Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 220. Wuzhong Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 221. Wuzhong Pharmaceutical Recent Developments
Table 222. Key Raw Materials Lists
Table 223. Raw Materials Key Suppliers Lists
Table 224. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Distributors List
Table 225. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Customers List
Table 226. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Trends
Table 227. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Drivers
Table 228. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Challenges
Table 229. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Restraints
Table 230. Research Programs/Design for This Report
Table 231. Key Data Information from Secondary Sources
Table 232. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Picture
Figure 2. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Share by Type in 2022 & 2029
Figure 4. Vials Product Picture
Figure 5. Prefilled Product Picture
Figure 6. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Share by Application in 2022 & 2029
Figure 8. Myelosuppressive Chemotherapy
Figure 9. Leukemia Chemotherapy
Figure 10. Others
Figure 11. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Report Years Considered
Figure 12. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue 2018-2029 (US$ Million)
Figure 14. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Region (2018-2029)
Figure 16. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales 2018-2029 ((K L)
Figure 17. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales YoY (2018-2029) & (K L)
Figure 19. US & Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales YoY (2018-2029) & (K L)
Figure 21. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales YoY (2018-2029) & (K L)
Figure 23.